BLB&G Partner Abe Alexander to Present to U.S. Food and Drug Administration on Securities Litigation in Biotech December 2, 2021 BLB&G partner Abe Alexander will present to the U.S. Food and Drug Administration’s Office of Regulatory Affairs on securities litigation in the biotech and life sciences industries on December 2, 2021. The program will discuss how the FDA's work to enforce federal food and drug regulations benefits investors, as well as consumers, by promoting integrity and transparency in the capital markets. Abe will explore some of the positive synergies between the FDA's enforcement work and institutional investors' efforts to enforce the federal securities laws through private litigation. Abe has successfully prosecuted numerous high-profile securities fraud cases that involve pharmaceuticals and medical devices. He recently presented a program on Biostatistics for Lawyers that you can read more about here. SEARCH NEWS & EVENTS GO Related Professional Abe Alexander Partner 212.554.1346 AWARDS Law360 Profiles Abe Alexander as Part of Series Honoring 2021 Rising Star Award Winners June 2, 2021 LEARN MORE NEWS Partner Avi Josefson Quoted by Law360 in Article on Current Status of Pandemic-Related Securities Suits March 11, 2021 LEARN MORE EVENTS BLB&G Partner Abe Alexander and Northeastern University Provost David Madigan Present Webinar on "Biostatistics for Lawyers" September 30, 2021 Copyright © 2021 Bernstein Litowitz Berger & Grossmann LLP All Rights Reserved. Attorney Advertising | Legal Notices / Privacy Policy | Credits | PortfolioWatch Login Accessibility